Sensorion SA (RFM)
XSTU
Closed
Aug 25, 2026
Day's Range
0.262052 wk Range
0.2235Overview - RFM - Sensorion SA
Key Statistics
Valuation
Enterprise Value
94.03M
P/E (Trailing)
‪-2.77‬
Price / Sales (TTM)
‪24.15‬
Price / Book
‪1.84‬
EV / EBITDA
‪-3.15‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-399.79%‬
Return on Assets
‪-26.12%‬
Return on Equity
‪-50.47%‬
Ownership
Shares Outstanding
300.34M
Float
300.40M
Held by Insiders
‪34.76%‬
Held by Institutions
‪35.52%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪0.2652‬
200-Day Avg
‪0.3286‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RFM - Sensorion SA
Peers - RFM - Sensorion SA
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- RFRFMXSTUSensorion SA136.56MMarket Cap-9.39%52-week change-2.77P/E (Trailing)‪0.00%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+5.19%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech Inc.8.64BMarket Cap+57.07%52-week change42.50P/E (Trailing)‪54.81%‬Profit Margin
- 2X10XSTUAbivax SA ADR8.59BMarket Cap+36.14%52-week change-20.91P/E (Trailing)‪0.00%‬Profit Margin
- 19XXSTUAxsome Therapeutics, Inc.7.98BMarket Cap+41.14%52-week change-47.55P/E (Trailing)‪92.56%‬Profit Margin
- 30JXSTUIdeaya Biosciences Inc.3.31BMarket Cap+38.45%52-week change-26.67P/E (Trailing)‪-74.75%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+65.82%52-week change-108.13P/E (Trailing)—Profit Margin
Profile Summary - RFM - Sensorion SA
About
Sensorion SA is a biopharmaceutical company dedicated to the development of innovative therapies for inner ear disorders. Known for its cutting-edge research in otoplatform technology, Sensorion aims to address conditions like sudden sensorineural hearing loss, tinnitus, and balance disorders. The company's primary…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
